Incidence and 5-year survival rate for head and neck cancers in Grenada compared to the African American population over the period 1991-2010

被引:2
|
作者
du Plessis, Maira [1 ]
Hage, Robert [1 ]
机构
[1] St Georges Univ, Dept Anat Sci, St Georges, Grenada
关键词
Oral cancer; Cancer in Grenada; Pharynx cancer; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; ORAL-CAVITY; CASE SERIES; EPIDEMIOLOGY; MANAGEMENT;
D O I
10.1007/s10552-017-0934-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Very little data exist on the incidence and burden of cancer in the individual Caribbean countries. Some data are available for larger areas, reported under a bigger geographical region; Latin America and the Caribbean, but many of the individual countries are not included. One of the main reasons is a lack of official cancer registries. Data are usually collected from hospital records or private physician records, and since it is not in an official registry, these data are not always accessible for inclusion in databases such as SEER and GLOBOCAN. Grenada is one of the countries that currently does not have a registry. Our aim is to report on the incidence for head and neck cancer with subcategories; hypopharynx, oropharynx, oral cavity, salivary glands, and larynx from data collected by the sole ear nose and throat specialist over a 20-year period. The age adjusted incidence per 100,000 for these cancers, whether combined or individually, is lower than that of similar populations. The incidence in males is only slightly higher than those reported in some parts of Africa. In females, only Eastern Africa is reported to have a lower incidence than that found in our study. While the incidence of oral cancers is lower than that of African Americans, the survival rate is comparable. Socioeconomic status, lack of infrastructure, and advanced stage at diagnosis appear to be closely related to the survival rate. Incidence reports suggest that incidence of head and neck cancers in individuals of African descent is lower than other populations. It is therefore not surprising that the incidence in Grenada is relatively low, although the incidence may be underestimated.
引用
收藏
页码:1227 / 1239
页数:13
相关论文
共 8 条
  • [1] Incidence and 5-year survival rate for head and neck cancers in Grenada compared to the African American population over the period 1991–2010
    Maira du Plessis
    Robert Hage
    Cancer Causes & Control, 2017, 28 : 1227 - 1239
  • [2] Annual incidence of insomnia in a population-based sample over a 5-year period
    Jarrin, D. C.
    Ivers, H.
    Merette, C.
    LeBlanc, M.
    Savard, J.
    Morin, C. M.
    JOURNAL OF SLEEP RESEARCH, 2016, 25 : 122 - 122
  • [3] ODONTOGENIC TUMORS IN AN AFRICAN POPULATION - ANALYSIS OF 29 CASES SEEN OVER A 5-YEAR PERIOD
    MOSADOMI, A
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1975, 40 (04): : 502 - 521
  • [4] Head-and-Neck Cancers as Second Primary Following an Index Head-and-Neck Cancer: Population-Based Outcomes Over a 25-Year Period
    Tiwana, M. S.
    Wu, J.
    Hay, J.
    Wong, F.
    Cheung, W.
    Olson, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S481 - S482
  • [5] Changes in social support and their impact on psychosocial outcome over a 5-year period for African American and White dementia caregivers
    Clay, Olivio J.
    Roth, David L.
    Wadley, Virginia G.
    Haley, William E.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (08) : 857 - 862
  • [6] An examination of racial differences in 5-year survival of cervical cancer among African American and white American women in the southeastern US from 1985 to 2010
    Weragoda, Janaka
    Azuero, Andres
    Badiga, Suguna
    Bell, Walter C.
    Matthews, Roland
    Piyathilake, Chandrika
    CANCER MEDICINE, 2016, 5 (08): : 2126 - 2135
  • [7] Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival (vol 11, pg 21, 2010)
    Bonner, J. A.
    Harari, P. M.
    Giralt, J.
    LANCET ONCOLOGY, 2010, 11 (01): : 14 - 14
  • [8] INTEGRATION OF SAFE INITIAL COMBINATION CHEMOTHERAPY (WITHOUT CISPLATIN) WITH A HIGH RESPONSE RATE AND LOCAL THERAPY FOR UNTREATED STAGE-III AND STAGE-IV EPIDERMOID CANCER OF THE HEAD AND NECK - 5-YEAR SURVIVAL-DATA
    PRICE, LA
    MACRAE, K
    HILL, BT
    CANCER TREATMENT REPORTS, 1983, 67 (06): : 535 - 539